Compounds > cromakalim
Page last updated: 2024-08-25

cromakalim and Allodynia

cromakalim has been researched along with Allodynia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Li, Z; Liu, X; Ren, X; Wang, W; Wang, Y; Wu, S; Zhang, K; Zhu, C1
Huang, ZJ; Liu, WT; Liu, YP; Song, XJ; Wu, XF; Zhang, YK1

Other Studies

2 other study(ies) available for cromakalim and Allodynia

ArticleYear
A c-Fos activation map in nitroglycerin/levcromakalim-induced models of migraine.
    The journal of headache and pain, 2022, Sep-30, Volume: 23, Issue:1

    Topics: Animals; Calcitonin Gene-Related Peptide; Calcitonin Gene-Related Peptide Receptor Antagonists; Cromakalim; Disease Models, Animal; Humans; Hyperalgesia; Mice; Migraine Disorders; Nitroglycerin; Pain; Proto-Oncogene Proteins c-fos; Receptors, Calcitonin Gene-Related Peptide

2022
Reopening of ATP-sensitive potassium channels reduces neuropathic pain and regulates astroglial gap junctions in the rat spinal cord.
    Pain, 2011, Volume: 152, Issue:11

    Topics: Animals; Astrocytes; ATP-Binding Cassette Transporters; Cromakalim; Gap Junctions; Hyperalgesia; KATP Channels; Male; Neuralgia; Potassium Channels, Inwardly Rectifying; Rats; Rats, Sprague-Dawley; Receptors, Drug; Sciatica; Spinal Cord; Sulfonylurea Receptors

2011